TD ASSET MANAGEMENT INC – Alnylam Pharmaceuticals, Inc. Transaction History
TD ASSET MANAGEMENT INC portfolio value:
$80.57M
portfolio value
TD ASSET MANAGEMENT INC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.86% | -15.45K shares | 22.19M | $200.16 | 384.81K |
| Q2 2022 | share | Increase | +1.93% | 7.58K shares | -5.74M | $145.85 | 400.26K |
| Q1 2022 | share | Decrease | -0.96% | -3.79K shares | -3.11M | $163.29 | 392.68K |
| Q4 2021 | share | Increase | +68.94% | 161.78K shares | 22.92M | $171.03 | 396.47K |
| Q3 2021 | share | Increase | +4.72% | 10.58K shares | 4.20M | $188.81 | 234.68K |
| Q2 2021 | share | Increase | +16.71% | 32.07K shares | 12.98M | $169.52 | 224.1K |
| Q1 2021 | share | Increase | +9.40% | 16.49K shares | 4.29M | $141.19 | 192.02K |
| Q4 2020 | share | Increase | +4.83% | 8.08K shares | -1.56M | $129.97 | 175.52K |
| Q3 2020 | share | Increase | +6.28% | 9.88K shares | 1.04M | $145.6 | 167.44K |
| Q2 2020 | share | Increase | +5.88% | 8.74K shares | 7.13M | $148.11 | 157.56K |
| Q1 2020 | share | Increase | +12.56% | 16.6K shares | 972K | $108.85 | 148.81K |
| Q4 2019 | share | Increase | +15.93% | 18.16K shares | 6.05M | $115.17 | 132.21K |
| Q3 2019 | share | Increase | +18.49% | 17.8K shares | 2.18M | $80.42 | 114.05K |
| Q2 2019 | share | Increase | +4.03% | 3.73K shares | -1.66M | $72.56 | 96.25K |
| Q1 2019 | share | Decrease | -1.26% | -1.18K shares | 1.81M | $93.45 | 92.52K |
| Q4 2018 | share | Decrease | -12.45% | -13.33K shares | -2.53M | $72.91 | 93.70K |
| Q3 2018 | share | Decrease | -15.24% | -19.25K shares | -3.07M | $87.52 | 107.03K |
| Q2 2018 | share | Decrease | -25.23% | -42.60K shares | -7.67M | $98.49 | 126.28K |
| Q1 2018 | share | Increase | +6.26% | 9.95K shares | -78K | $119.1 | 168.89K |
| Q4 2017 | share | Increase | +14.52% | 20.15K shares | 3.88M | $127.05 | 158.94K |
| Q3 2017 | share | Increase | +6.83% | 8.87K shares | 5.94M | $117.49 | 138.79K |
| Q2 2017 | share | Increase | +36.76% | 34.91K shares | 5.49M | $79.76 | 129.91K |
| Q1 2017 | share | Increase | +2.37% | 2.2K shares | 1.39M | $51.25 | 95K |
| Q4 2016 | share | Increase | +3.64% | 3.26K shares | -2.59M | $37.44 | 92.8K |
| Q3 2016 | share | Increase | +0.29% | 258 shares | 1.11M | $67.78 | 89.53K |
| Q2 2016 | share | Increase | +278.31% | 65.68K shares | 3.47M | $55.49 | 89.28K |
| Q1 2016 | share | Increase | +10.80% | 2.3K shares | -524K | $62.77 | 23.6K |